Results 51 to 60 of about 4,373 (200)

Retinal glycoprotein enrichment by concanavalin a enabled identification of novel membrane autoantigen synaptotagmin-1 in equine recurrent uveitis. [PDF]

open access: yes, 2012
Complete knowledge of autoantigen spectra is crucial for understanding pathomechanisms of autoimmune diseases like equine recurrent uveitis (ERU), a spontaneous model for human autoimmune uveitis. While several ERU autoantigens were identified previously,
Cornelia A. Deeg   +23 more
core   +1 more source

Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine

open access: yesNeuropsychiatric Disease and Treatment, 2011
Sabine Lindquist, Martin StangelSection Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, GermanyAbstract: In Lambert–Eaton myasthenic syndrome (LEMS), antibodies against presynaptic ...
Lindquist S, Stangel M
doaj  

Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG)

open access: yesTherapeutic Advances in Neurological Disorders, 2020
Neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitis (AE), myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are antibody-mediated neurological diseases.
Ayse Altintas   +9 more
doaj   +1 more source

MGBase: A Global, Observational Registry for Collaborative Research in Myasthenia Gravis

open access: yesMuscle &Nerve, Volume 72, Issue 3, Page 424-432, September 2025.
ABSTRACT Introduction/Aims Patient registries are valuable tools for outcomes research in rare diseases such as myasthenia gravis (MG). Existing MG registries are limited by factors including a lack of geographical scope. MGBase has been designed as a global, observational registry aimed at studying clinical practice outcomes in MG.
Katherine A. Buzzard   +28 more
wiley   +1 more source

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.

open access: yes, 2008
Lambert-Eaton myasthenic syndrome (LEMS) is an immune-mediated disorder of the neuromuscular junction that rarely is associated with cerebellar ataxia (CA).
Scola, RH   +7 more
core   +1 more source

Myasthenia gravis and Lambert-Eaton myasthenic syndrome: treatment options and guidance for management during COVID-19 pandemic

open access: yesNeurologijos seminarai, 2020
Myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are immune-mediated neurologic disorders characterized by muscle weakness and fatigue. MG is the most common neuromuscular junction disorder while LEMS is an extraordinary rare disease.
A. Klimašauskienė , R. Bunevičiūtė
doaj   +1 more source

Efficacy and Safety of Efgartigimod for Patients With Myasthenia Gravis in a Real‐World Cohort of 77 Patients

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 4, April 2025.
This real‐world study of 77 myasthenia gravis (MG) patients treated with efgartigimod showed rapid symptom improvement across disease severities. Sustained efficacy was achieved with repeated cycles, positioning efgartigimod as a promising MG therapy combining swift response and durable maintenance benefits. ABSTRACT Aims Efgartigimod, a first‐in‐class
Sijia Hao   +12 more
wiley   +1 more source

Clinical Features of Glutamic Acid Decarboxylase‐65 Neurological Autoimmunity: A Case Series From China

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 2, February 2025.
The clinical spectrum of GAD65 autoimmune neurological diseases appeared highly diverse. Immunotherapy can benefit the majority of patients, and early treatment appeared to be associated with good prognosis. RTX may be more effective than MMF; however, this requires more rigorous prospective studies to explore.
Zhandong Qiu   +18 more
wiley   +1 more source

Lamber-Eaton myasthenic syndrome associated with multiple myeloma: A case report

open access: yesCurrent Problems in Cancer: Case Reports
Background: Lambert-Eaton myasthenic syndrome (LEMS) is an uncommon illness of the neuromuscular junction. It typically manifests as a combination of proximal muscular weakness, autonomic dysfunction, and areflexia.
Sebastian S Casillas-Berumen   +7 more
doaj   +1 more source

Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review

open access: yesJournal of International Medical Research, 2020
Patients with anti-CV2/collapsin response mediator protein (CRMP)5 antibodies present with more frequent chorea, cerebellar ataxia, uveo/retinal symptoms, and Lambert–Eaton myasthenic syndrome or myasthenia gravis.
Jinhua Yan   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy